Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Vitiligo: early-phase trial registry
3 of 16 indexed Vitiligo trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #1,060 of 28,707 conditions by registered trial count.
16 US clinical trials · 3 currently recruiting · #1,060 of 28,707 conditions by registered trial count
Vitiligo: 16 US clinical trials tracked, 3 recruiting.
Vitiligo is the subject of 16 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 8 in Phase 1-2 (earlier-stage). The most active sponsor is Medical University of South Carolina, running 2 of these trials.
Enrollment posture brief
Registry condition vitiligo
OPEN 3 | RECR 19% | LATE 3 | EARLY 8 | RANK #1060 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Bacterial Vaginosis (19% recruiting · 16 trials)
Vitiligo lists 3 open slots (19% of 16 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Vitiligo on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Vitiligo is recruiting below its size-band peers.
3 of 16 indexed trials (18.8%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Vitiligo trials is spread across many organizations.
Medical University of South Carolina accounts for 2 of 16 trials (12.5%). 15 distinct sponsors appear on at least one study for this condition label.
-
Typical Vitiligo enrolment sits around 80 participants.
Median target enrolment is 80 among the 16 trials that report a genuine target (sentinel values excluded). 9 of those (56.3%) plan for fewer than 100 participants.
-
Vitiligo research is mostly interventional.
14 interventional and 2 observational studies make up this index (87.5% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
16 total, page 1 of 1
A 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Participants With Nonsegmental Vitiligo
Pfizer
NCT06163326
The Gut and Skin Microbiome in Vitiligo Disease Progression
Northwestern University
NCT03577327
A Study of DR-01 in Subjects With Alopecia Areata and Vitiligo
Dren Bio
NCT06602232
A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC
Target PharmaSolutions
NCT03661866
A Study To Assess Adverse Events and Effectiveness of Upadacitinib Oral Tablets in Adult and Adolescent Participants With Vitiligo
AbbVie
NCT06118411
A Study to Compare the Efficacy and Safety of SCENESSE and Narrow-Band Ultraviolet (NB-UVB) Light Versus NB-UVB Light Alone in Patients With Vitiligo
Clinuvel
NCT06109649
A Trial to Test the Safety and Efficacy of TEV-53408 in Treating Vitiligo
Teva Branded Pharmaceutical Products R&D
NCT06625177
Daily Topical Rapamycin for Vitiligo
Medical University of South Carolina
NCT05342519
A Study of INCB018424 Phosphate Cream in Subjects With Vitiligo
Incyte Corporation
NCT03099304
Repigmentation of Stable Vitiligo Lesions Using Spray-On Skin™ Cells
Avita Medical
NCT05971381
Evaluation of AMG 714 for Vitiligo
National Institute of Allergy and Infectious Diseases (NIAID)
NCT04338581
A Study of ATI-50002 Topical Solution for the Treatment of Vitiligo
Aclaris Therapeutics
NCT03468855
Combined Therapy With Narrow-Band Ultraviolet B Phototherapy and Apremilast for the Treatment of Vitiligo
Icahn School of Medicine at Mount Sinai
NCT03123016
Photocil (Topical) for the Treatment of Vitiligo
Applied Biology
NCT01992185
Early Molecular Changes in Vitiligo After Narrowband Ultraviolet Therapy
Johns Hopkins University
NCT03270241
Effect of Microneedling, Bimatoprost and Excimer in Vitiligo Treatment
Medical University of South Carolina
NCT04738149
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 3 |
| Phase 2 | 5 |
| Phase 3 | 3 |
Top Sponsors
Named interventions
Most-linked intervention names on Vitiligo records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Vitiligo trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Vitiligo page
16 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Vitiligo trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Medical University of South Carolina sponsors the most Vitiligo trials on record, review their full trial history before evaluating a specific study. See Medical University of South Carolina's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Vitiligo condition card totals 16 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.